Gert J. Lammers

Heemstede, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138 publications

Veni FINI: a new tool to assess functional impact in narcolepsy.

Veni FINI: a new tool to assess functional impact in narcolepsy.

Journal: Sleep
Published: May 21, 2026

Efficacy, safety, and tolerability of low sodium oxybate for nocturnal cluster headache attacks in chronic cluster headache: protocol for a phase II randomized, double-blind, placebo-controlled, trial (SUNCET).

Efficacy, safety, and tolerability of low sodium oxybate for nocturnal cluster headache attacks in chronic cluster headache: protocol for a phase II randomized, double-blind, placebo-controlled, trial (SUNCET).

Journal: Pain management
Published: April 20, 2026

Stimulating amyloid-β clearance in cerebral amyloid angiopathy with low-sodium oxybate and/or non-invasive vagus nerve stimulation (Clear-Brain): study protocol for a randomised pre-post trial.

Stimulating amyloid-β clearance in cerebral amyloid angiopathy with low-sodium oxybate and/or non-invasive vagus nerve stimulation (Clear-Brain): study protocol for a randomised pre-post trial.

Journal: BMJ open
Published: March 11, 2026

Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Neurology
Published: February 27, 2026

The Development of the European Sleep Questionnaire A New Patient-Reported Outcome Measure.

The Development of the European Sleep Questionnaire A New Patient-Reported Outcome Measure.

Journal: Journal of sleep research
Published: February 11, 2026

Network Analysis in Central Disorders of Hypersomnolence: Insight Into Relationships Between Symptoms, Mental Health, and Quality of Life.

Network Analysis in Central Disorders of Hypersomnolence: Insight Into Relationships Between Symptoms, Mental Health, and Quality of Life.

Journal: Journal of sleep research
Published: January 22, 2026

Novel genes associated with hypocretin-producing neurons identified by human gene expression profiling.

Novel genes associated with hypocretin-producing neurons identified by human gene expression profiling.

Journal: Journal of neuroimmunology
Published: December 15, 2025

Effects of Oveporexton, an Orexin Receptor 2-Selective Agonist, on Cognition in Narcolepsy Type 1: A Secondary Analysis of a Randomized Clinical Trial.

Effects of Oveporexton, an Orexin Receptor 2-Selective Agonist, on Cognition in Narcolepsy Type 1: A Secondary Analysis of a Randomized Clinical Trial.

Journal: JAMA neurology
Published: December 08, 2025

iSPHYNCS: Unsupervised Clustering in Questionnaires and Metadata Reveals Distinct Subtypes in the Narcolepsy Borderland.

iSPHYNCS: Unsupervised Clustering in Questionnaires and Metadata Reveals Distinct Subtypes in the Narcolepsy Borderland.

Journal: Journal of sleep research
Published: July 02, 2025

Sleep Medicine-What's in a Name?

Sleep Medicine-What's in a Name?

Journal: Journal of sleep research
Published: July 01, 2025

Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1.

Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1.

Journal: The New England journal of medicine
Published: May 14, 2025

Corticotropin-Releasing Hormone (CRH) in Murine Narcolepsy: What Do Genetic and Immune Models Tell Us?

Corticotropin-Releasing Hormone (CRH) in Murine Narcolepsy: What Do Genetic and Immune Models Tell Us?

Journal: Journal of sleep research
Published: April 29, 2025
Showing 1-12 of 138

Last Updated: 09/26/2026